Piper Sandler began coverage on shares of Heartflow (NASDAQ:HTFL – Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The firm issued an overweight rating and a $38.00 target price on the stock.
A number of other research analysts have also recently issued reports on the company. Canaccord Genuity Group initiated coverage on Heartflow in a research report on Tuesday. They issued a “buy” rating and a $35.00 target price on the stock. Wall Street Zen upgraded Heartflow to a “hold” rating in a research report on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $35.80.
Read Our Latest Research Report on HTFL
Heartflow Stock Down 1.1%
About Heartflow
We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.
Read More
- Five stocks we like better than Heartflow
- The 3 Best Retail Stocks to Shop for in August
- Amazon Faces Rare Downgrade—Is the Rally at Risk?
- The Most Important Warren Buffett Stock for Investors: His Own
- CrowdStrike Tests $412 Support as Options Traders Turn Bullish
- What is the S&P/TSX Index?
- Dueling Insider Moves: Heavy Buying Here, Big Selling There
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
